medcomms
Follow
Find
283 views | +0 today
medcomms
raising awareness of medicines via education and promotion
Curated by Laura Browne
Your new post is loading...
Your new post is loading...
Scooped by Laura Browne
Scoop.it!

Doctors Believe Using Health Apps Will Cut Down on Visits [INFOGRAPHIC]

Doctors Believe Using Health Apps Will Cut Down on Visits [INFOGRAPHIC] | medcomms | Scoop.it
Many doctors believe that accessing apps that keep track of your health will help cut down on doctor visits, a new report suggests.
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

iRounds Social Network Helps Doctors Get Second Opinions

iRounds Social Network Helps Doctors Get Second Opinions | medcomms | Scoop.it
iRounds -- which is being called Twitter for doctors -- gives physicians a community to discuss cases and get second opinions.
more...
No comment yet.
Rescooped by Laura Browne from Patient
Scoop.it!

Mobile health is taking off but what’s still in its way?

Mobile health is taking off but what’s still in its way? | medcomms | Scoop.it

There may be 12,000 apps out there but they’re not 12,000 good apps,” Chris Wasden, Global Healthcare Innovation Leader for PwC, said at the MedCity Converge health tech conference Tuesday.

 

“They’re mostly bad apps that people rarely use.”

 

Aside from the issues with the apps themselves, he said recent research conducted by PwC found that even though patients are eager to adopt mobile health, doctors and the larger system surrounding them are reluctant to change things up.

 

“Consumers are demanding it,” he said. “Doctors see mobile healthcare being much more transformative and disruptive to their practice. This transformation and disruption is so painful that they’re very resistant to doing those changes.”


Via Andrew Spong
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Charts & Data

Charts & Data | medcomms | Scoop.it
Battle of The Sexes Social Web...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Health technology and patient-centered principles shown to improve care - amednews.com

Using both patient-centred care prinicples and health information technology improves care

more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Pharma cos may have to shift business strategy due to slow growth: Report - Economic Times

Pharma cos may have to shift business strategy due to slow growth: Report - Economic Times | medcomms | Scoop.it
Pharma cos may have to shift business strategy due to slow growth: ReportEconomic TimesThe North American market is one of the biggest pharma markets in the world at $345 billion, with a growth rate of 2.4%, according to figures available with IMS...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

What health information do people in Europe want from pharma? - Digital Handbook - European online audiences

What health information do people in Europe want from pharma? - Digital Handbook - European online audiences | medcomms | Scoop.it
A sizable minority of online Europeans want to learn more about prescription drugs directly from the industry - PMLiVE...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

NICE rejects Roche's Avastin for advanced breast cancer - NEWS - General articles - Pharmaceutical Industry - PMLiVE

NICE rejects Roche's Avastin for advanced breast cancer - NEWS - General articles - Pharmaceutical Industry - PMLiVE | medcomms | Scoop.it
Pharmaceutical Industry | NEWS | General | NICE rejects Roche's Avastin for advanced breast cancer - Decision represents the latest blow to Roche's blockbuster cancer drug | PMLiVE...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Johnson & Johnson fined $1.1bn for misleading doctors over anti-psychotic drug Risperdal - Telegraph

Johnson & Johnson fined $1.1bn for misleading doctors over anti-psychotic drug Risperdal - Telegraph | medcomms | Scoop.it
Johnson & Johnson has been ordered to pay a $1.1bn (£691m) fine by a US court after a jury found the pharmaceutical company misled doctors over the risks associated with a best-selling anti-psychotic medicine.
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Healthcare and Hospital Social Media Infographic

www.healthcareitnews.com brings us an interesting infographic showing how healthcare professionals are using social media. The data are collected from a.
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Survey: Attitudes on Social Media in Healthcare Communication (2012) : Ideahaus® Professional Community

Survey: Attitudes on Social Media in Healthcare Communication (2012) : Ideahaus® Professional Community | medcomms | Scoop.it

Survey: Attitudes on Social Media in Healthcare Communication (2012) http://t.co/ZyCwKNFl via @ideahaus (Survey) #pharma #hcsm...

more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Social media challenges & benefits for pharma companies ...

Social media challenges & benefits for pharma companies ... | medcomms | Scoop.it
This is an article that highlights the challenges to social media in the pharmaceutical industry and the benefits of overcoming them. ... “…the FDA social media regulations for pharma marketing are extremely strict…” ...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Pharma gets social: China – pharma’s social media frontier | pharmaphorum

Pharma gets social: China – pharma’s social media frontier | pharmaphorum | medcomms | Scoop.it
This article compares the social media sites in the heavily-regulated, emerging market China, to Facebook & Twitter, commonly used in the Westernised countries.
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

UNDERSTANDING THE ‘MODERN’ PATIENT - How do we use the Web for health related matters?   - Readings - Oxyme

UNDERSTANDING THE ‘MODERN’ PATIENT - How do we use the Web for health related matters?   - Readings - Oxyme | medcomms | Scoop.it
Why Health and the Web are so important

Health is one of the most important aspects of any...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Pharma Marketing Blog: Are Pinterest Women & Virality Worth It to Pharma Marketers?

more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Is Marketing the Enemy of Pharmaceutical Innovation?

Is Marketing the Enemy of Pharmaceutical Innovation? | medcomms | Scoop.it
E SSAYS Is Marketing the Enemy of Pharmaceutical Innovation? BY KALMAN APPLBAUM Clinical trials are the most credible and powerful form of marketing in the prelaunch period.
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Pharma Marketing Blog: Blaming the FDA for Pharma's Tepid Use of Social Media

more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Patients want eHealth option but not at expense of seeing doctors - NEWS - articles - Pharmaceutical Industry - PMLiVE

Patients want eHealth option but not at expense of seeing doctors - NEWS - articles - Pharmaceutical Industry - PMLiVE | medcomms | Scoop.it
Pharmaceutical Industry | NEWS | | Patients want eHealth option but not at expense of seeing doctors - And email more important to patients than mobile phone-only reminders | PMLiVE...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Digital Intelligence roundup - NEWS - articles - Pharmaceutical Industry - PMLiVE

Pharmaceutical Industry | NEWS | | Digital Intelligence roundup - Includes Sanofi’s diabetes dictionary, a new dosing calculator app from CSL Behring and a digital tip of the week | PMLiVE...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

GSK pay $3bn to settle drug-marketing case - News & analysis - Communiqué

GSK pay $3bn to settle drug-marketing case | News Article | UK drug-maker pleads guilty for promoting a number of drugs in the US off-label | Communiqué...
more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Boehringer partners with Harvard to discover drugs for conditions lacking treatments

Boehringer Ingelheim has formed a partnership with Harvard University in Massachusetts, US, to research treatments in area of “unmet medical need”.

This includes conditions in oncology, cardiometabolic, fibrotic and infectious diseases, with the two partners aiming to identify and investigate signalling pathways in the body that have yet to be investigated for a medical use.

The collaboration will see Germany-based pharma company Boehringer support research projects from proposals selected by a joint research committee, comprised of representatives from the Harvard Medical School ICCB-Longwood Screening Facility, various institutions affiliated with Harvard and Boehringer itself.

Eight projects have already been selected for support, with research covering stem cell survival in cancer and the replication of viruses.

Each is using specifically tailored screening systems to carry out RNAi screening projects.

"We are very pleased to sponsor the joint research programs by the distinguished scientists at Harvard in these important fields of medical need,” said Dr Adrian Carter, corporate VP of global research networking at Boehringer.

"We believe that this research collaboration with Harvard will help us create new medicines for a variety of important diseases that afflict our society today".

This collaboration is only the latest in a series of partnerships Harvard has formed with pharma, with existing agreements already in place with UCB for conditions related to the central nervous system and immunology and Sanofi for conditions including cancer and diabetes.

The university is also working with GlaxoSmithKline (GSK) to utilise stem cell research in the discovery of new medicines.

more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Vodaphone and Exco InTouch Partner to Marry Mobile Communications with Patient Engagement for Better Data Reporting in Clinical Trials

Vodaphone and Exco InTouch Partner to Marry Mobile Communications with Patient Engagement for Better Data Reporting in Clinical Trials | medcomms | Scoop.it

Vodafone and Exco InTouch partner to marry mobile communications with patient engagement for better data reporting in clinical trial

more...
No comment yet.
Scooped by Laura Browne
Scoop.it!

Part 1 of 2: Interview with Kevin Michels-Kim, digital strategist and ex multichannel marketing at Merck & Co - DigiPharm - Digital Marketing Strategies for Pharmaceutical Products

excerpt:       "It will be some time before we know if multichannel is a success for the industry as a whole, but I suspect individual company satisfaction with their multichannel approach is mixed

more...
No comment yet.